Suzanne Cory is a molecular biologist who studies the genetics of the immune system and cancer. Her notable contributions, made together with longstanding scientific partner and Royal Society Fellow Jerry Adams, include finding 5’ caps on eukaryotic messenger RNAs; furthering our understanding of immunoglobulin (Ig) gene diversity; and the discovery that chromosome translocations linking the c-myc proto-oncogene to Ig loci drive the development of human Burkitt’s lymphoma and mouse plasmacytoma.
She uses mouse models to dissect the role of the Bcl-2 protein family in regulating apoptosis, particularly during haemopoiesis. Together with her colleague, she is using this knowledge to develop more effective treatments for cancer.
For her distinguished work on the molecular basis of cancer. She pioneered the use of transgenic mice to elucidate the role of various oncogenes in lymphoid malignancies.